CONSOLIDATED BALANCE SHEETS - USD ($)	Jul. 31, 2021	Jul. 31, 2020
Current assets:
Cash	$ 32,473	$ 18,281
Marketable securities	533,751	10,436
Other prepaid expenses and current assets	279,219	2,945
Total current assets	845,443	31,662
Property and equipment, net	31,046
Intellectual property	143,957	300
Project development costs, including $154,221 and $51,500 incurred with related parties, at July 31, 2021, and 2020, respectively	4,915,610	134,413
Total assets	5,936,056	166,375
Current liabilities:
Accounts payable and accrued expenses	710,656	170,972
Compensation and related expenses payable, including $450,000 and $90,000 to a related party, at July 31, 2021, and 2020, respectively	527,109	120,317
Deferred revenue	63,071
Due to related party	3,466
Payable for rescinded stock subscription receivable	60,000
Unsecured promissory notes payable to related party, including accrued interest payable of $24,364	1,525,298
Unsecured promissory note payable, including accrued interest payable of $2,051	177,051
Secured multiple advance promissory note payable to related party, including accrued interest payable of $77,722	1,077,722
Convertible note payable, net of debt discount of $47,324 debt issuance costs related to the convertible note payable of $2,135, including accrued interest payable of $811	80,101
Derivative liability, net of issuance costs related to the conversion option of $1,378	49,252
Contingent loss related to default of convertible note payable	64,375
Convertible promissory note payable, including accrued interest of $427		25,427
Total current liabilities	4,338,101	316,716
Convertible promissory note payable including accrued interest payable of $4,356	104,356
Total liabilities	4,442,457	316,716
Stockholders’ equity (deficiency):
Series B preferred stock, $0.0001 par value; authorized – 2,000,000 shares; issued and outstanding – 1,347 shares	202	202
Common stock, $0.0001 par value; authorized – 200,000,000 shares; issued and outstanding – 136,070,171 shares and 96,691,761 shares at July 31, 2021, and 2020, respectively	13,607	9,669
Additional paid-in capital	4,880,354	1,456,644
Common stock subscription receivable from related party	(482,600)	(550,000)
Accumulated deficit	(2,918,036)	(1,066,928)
Total stockholders’ equity (deficiency)	1,493,599	(150,341)
Total liabilities and stockholders’ equity (deficiency)	5,936,056	166,375
Series B Preferred Stock [Member]
Stockholders’ equity (deficiency):
Series B preferred stock, $0.0001 par value; authorized – 2,000,000 shares; issued and outstanding – 1,347 shares	$ 72	$ 72